eagle-i Harvard UniversityHarvard University
See it in Search

Harvard Office of Technology Development

Location: Gordon Hall Suite 414, 25 Shattuck Street, Boston, MA 02115 USA, Holyoke Center Suite 727E, 1350 Massachusetts Avenue, Cambridge, MA 02138 USA

Summary:

"The Harvard University Office of Technology Development (OTD) provides a one-stop shop to advance the development of groundbreaking discoveries by fostering strategic collaborations with industry through licensing, sponsored research and new venture agreements.

Our specific objectives include:

* Ensuring that Harvard research results are made widely available and transformed for public use and benefit.
* Serving as a dynamic bridge from laboratory to industry to make certain that promising new technologies are translated into products and services that benefit society.
* Evaluating, patenting and licensing inventions and discoveries made by faculty of Harvard University, Harvard Medical School, Harvard School of Public Health, the School of Engineering and Applied Sciences, and the Wyss Institute.
* Stimulating innovation and technology development within the Harvard community and securing all necessary protection of the resulting intellectual property.
* Licensing Harvard technologies to strong, effective partners.
* Establishing start up ventures and building value around Harvard innovations.
* Building sponsored research collaborations with industry around faculty-initiated applied research projects."

Keywords: micro/nanotechnology, drug discovery, chemicals and materials, energy, engineering/communications, stem cells/regenerative medicine, medical devices, medical diagnostics, therapeutics/vaccines, disease areas, genomics/proteomics

Affiliations:

People:

      Member: Benson, Robert
      Role: Director of Business Development - Engineering and Physical Sciences

      Member: Berlin, Vivian
      Role: Director of Business Development - Life Sciences

      Member: Brass, Laura
      Role: Director of Business Development - Life Sciences

      Member: Craig, Anne
      Role: Director of Intellectual Property

      Member: Fenerjian, Maryanne
      Role: Director of Technology Transfer Policy

      Member: Jacobson, David
      Role: Associate Director of Business Development - Life Sciences

      Member: Keith, Curtis
      Role: Chief Scientific Officer - Technology Development Accelerator Fund

      Member: Kohlberg, Isaac
      Role: Chief Technology Development Officer, Senior Associate Provost

      Member: Leung, Grace
      Role: Business Development Associate - Life Sciences

      Member: Liss, Sam
      Role: Director of Business Development - Engineering and Physical Sciences

      Member: McNulty, Adam
      Role: Associate Director of Business Development - Life Sciences

      Member: Moran, Alexis
      Role: Business Development Associate - Life Sciences

      Member: Natkanski, Chris
      Role: Senior Associate Director of Technology Transactions

      Member: Preminger, Michal
      Role: Executive Director of Harvard Medical School Office of Technology Development

      Member: Rothfuss, Cris
      Role: Director of Technology Transactions

      Member: Schiller, Pierce
      Role: Business Development Associate - Engineering and Physical Sciences

      Member: Shalom-Berensohn, Efrat
      Role: Associate Director of Technology Transactions

      Member: Smith, Elizabeth
      Role: Senior Associate Director of Technology Transactions

      Member: Staunton, Jane
      Role: Senior Associate Director of Corporate Alliances

    Resources:

    Services

    • Access to available technologies for licensing ( Access service )

      The Office of Technology Development (OTD) has an extensive portfolio of technologies available for licensing. These technologies span a wide range of subject areas including:

      * Biomedical Research Tools
      * Chemistry and Materials
      * Disease Areas
      * Energy
      * Engineering / Communications
      * Microtechnology / Nanotechnology
      * Medical Devices
      * Medical Diagnostics
      * Physics
      * Specialized Technology
      * Therapeutics / Vaccines

      Keywords: micro/nanotechnology, drug discovery, chemicals and materials, energy, engineering/communications, stem cells/regenerative medicine, medical devices, medical diagnostics, therapeutics/vaccines, disease areas, genomics/proteomics

    • Advancement of research discoveries ( Support service )

      The Office of Technology Development (OTD) provides researchers with an easily accessible source of expertise and experience for protecting your inventions and developing strategic industry collaborations through licensing, sponsored research and new venture agreements. OTD streamlines the process of technology transfer by making full use of its staff of professionals with broad experiences in science, business development, intellectual property, and contract law. OTD assures researchers of an efficient and productive path to technology transfer; researchers can subsequently focus on their research, continuing to work and publishing results without interference, while remaining confident that their works are properly protected.

    • Assessment of research inventions ( Support service )

      The reporting of any potential inventions to the Office of Technology Development (OTD) is integral to academic discovery as most scientific research at the University receives funding from either federal or private sponsors who require such reporting. OTD evaluates inventions for patentability and will advise their creators how to avoid premature disclosure to third parties that may jeopardize its potential commercial value. OTD recognizes that publishing and scientific discussion are of paramount importance and, when addressed at an early stage, these activities can remain both protected and unhindered.

      The reporting procedure is accomplished through a simple Report of Invention Form.

    • Assistance with industry partnership and licensing ( Support service )

      A fundamental step in making an invention available to the public is to develop technology transfer agreements with an industrial partner; the Office of Technology Development (OTD) selects industrial partners that are well-equipped and well-positioned to commercialize the technology. In structuring partnership agreements with licensees, OTD negotiates terms that benefit all parties concerned: the inventor, the University, the partner, and the public. OTD also negotiates key elements of a license agreement including provisions governing the scope of the license (exclusive or non-exclusive rights), the breadth of the field, reporting and diligence obligations of the licensee to Harvard, and royalty considerations payable to Harvard to ensure that fair value will be received based on future sales of any licensed products.

    • Assistance with industry-sponsored research and collaborations ( Support service )

      The Office of Technology Development (OTD) is responsible for sponsored research in which faculty-driven projects are supported by external funding from industry. Industry-sponsored research agreements (ISRAs) are a natural extension of OTD’s licensing activities. With OTD’s knowledge of the market, business contacts, and ability to cultivate and sustain productive relationships with industry, OTD helps researchers form strong collaborations even when commercialization is still far in the future. The collaborations include broad-based strategic alliances with industry that may involve funding of multiple laboratories performing research around a common theme. OTD takes great care not to limit inventors’ rights to publish and present their research findings. OTD understands the culture of both industry and the university so is able to craft successful ISRAs that meet the needs to all concerned, protecting academic freedom while helping advance research and innovation.

    • Assistance with start-up company formation ( Support service )

      Certain inventions may justify the formation of a start-up company. The Office of Technology Development (OTD) can help determine whether this path is the best way to commercialize an invention by analyzing a variety of factors including:

      * the potential of the technology to provide a platform for multiple product or market opportunities;
      * the competitive environment;
      * limited interest of existing companies in licensing the technology;
      * availability of venture capital together with interest and track record of likely investors;
      * level of commitment from the inventor(s) to the commercialization process;
      * the presence of a true business “champion” both for the technology and for the new venture; and
      * the management team of the proposed start-up.
      OTD provides support to interested faculty members whose inventions warrant the creation of a start-up company. OTD can:
      * Provide an initial sounding board for inventors to explore their startup ideas
      * Protect the intellectual property that will undergird the new company
      * Make introductions to entrepreneurs, angels, venture capital (VC) investors
      * Provide assistance with business planning
      * Work with inventors on competitive analysis, market assessment, investor pitches

    • Intellectual property protection ( Support service )

      An invention must be protected if it is to be commercialized in the best possible manner to benefit society, the inventor, and the University; a patent is the surest means to protect an invention. A patent prevents others from making, using, or selling an inventor’s intellectual property. In the U.S., this protection lasts for 20 years from the date of filing with varying periods of protection in foreign jurisdictions. The Office of Technology Development (OTD) provides researchers with advice on the patentability of an invention. To be patentable, a discovery must meet three basic criteria:
      * It must be useful;
      * It must be novel; and
      * It must not be obvious

      If an invention meets these criteria, OTD files a patent. If an invention requires further development and validation before a patent is filed, OTD shepherds the process and provides specific advice at critical points.

    • Marketing of research inventions ( Support service )

      The Office of Technology Development (OTD) provides expert guidance and assistance; OTD packages a researcher’s invention, target it to market, design the value proposition for the technology, and prepare an opportunity prospectus for potential partners and/or investors whom we identify with researcher input, leveraging our extensive network of contacts in the business and venture community. OTD then proceeds to hold preliminary discussions and analyze the best path forward. OTD encourages researchers to cultivate their own relationships with industry and explore potential mutual interests; OTD stands ready to coach or assist, as desired, in such interactions, providing advice and counsel as appropriate.

    • Negotiation and licensing of research technologies ( Support service )

      Through careful planning, skilled management, and well-structured agreements, Harvard researchers and industrial partners can collaborate fur mutual, sustained benefit. The primary types of agreements negotiated by the Office of Technology Development (OTD) include:

      * Confidentiality Agreements (CDAs) or Non-Disclosure Agreements (NDAs) to protect the confidentiality of an invention during evaluation by potential licensees and industry collaborators;
      * Industry-Sponsored Research Agreements (ISRAs) or Research Collaboration Agreements (RCAs) – IRSAs describe the terms under which sponsors provide support for faculty-initiated research projects while RCAs are similar to ISRAs, but contemplate the sponsor performing a collaborative role in research;
      * Inter-Institutional Agreements (IIAs) describe the terms under which two or more universities collaborate to market, license, and share revenues that may be received from licensing jointly owned intellectual property;
      * License Agreements describe the rights and responsibilities related to the use, development, and sales of commercial products covered by intellectual property developed at Harvard by an established company or a start-up company. License Agreements typically include a specific, dedicated plan that sets forth the steps that the licensee will take to develop and commercialize the licensed technology.
      * Material Transfer Agreements (see Service: Material Transfer Agreements)
      * Option Agreements (or Option Provisions) within ISRAs describe the conditions under which an industrial sponsor is granted the right to negotiate a license to intellectual property. Option Agreements may also be entered into with a company that wishes to evaluate a specified technology prior to entering into a full License Agreement.

    • Negotiation of Material Transfer Agreements ( Support service )

      Scientific research often requires the exchange of propriety physical materials among researchers such as cell lines, plasmid constructs, pharmaceuticals and chemicals. MTAs offer important protections regarding such issues as ownership, the ability to publish, and rights to resulting inventions necessary, among other, to ensure the investigator’s freedom to access additional materials as well as to collaborate with industry and license future inventions. The Office of Technology Development (OTD) negotiates carefully crafted Material Transfer Agreements (MTAs), a contract governing the incoming or outgoing exchange of tangible research materials between Harvard researchers and other academia, government, and commercial organizations.

    • Technology Development Accelerator Fund ( Support service )

      The primary obstacle to developing university technology and partnering with industry is the gap (sometimes referred to colloquially as “death valley”) that exists between early-stage research results and key proof-of-principle data required for industry to make a commitment and invest in the technology for further development and commercialization. The Technology Development Accelerator Fund, managed by the Office of Technology Development (OTD), is a dedicated funding initiative by Harvard to close this gap by providing funding for projects in the “gap” phase with a high probability of eventual commercial success. Faculty proposals are reviewed and selected for funding by an external advisory committee comprised of leaders from industry and the venture community. The committee’s expertise, together with the expertise of the Accelerator’s Chief Scientific Officer, are available to provide advice and guidance to the recipients of Accelerator funding as needed.

    • Use of the Collaborative Research Opportunity Finder ( Access service )

      The Harvard Office of Technology Development (OTD) offers an online tool known as the Collaborative Research Opportunity (CROP) Finder that allows those working in the life science industry to explore commercial partnerships with talented research faculty at Harvard. The OTD CROP Finder is designed to enable users to quickly identify research opportunities of interest. Users can access laboratory profiles that highlight the research focus, core competences, unique resources, and significant practical applications that may arise from discoveries made in the laboratory.
      If you are a Harvard investigator who is not yet represented on CROP and would like to be included, please contact OTD.


    Web Links:

    Last updated: 2013-09-13T10:55:26.152-05:00

    Copyright © 2016 by the President and Fellows of Harvard College
    The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016